Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 70 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Cholongitas, Evangelos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Pipili, C., & Cholongitas E. (2009).  Is pulverized levothyroxine a better therapeutic option in patients with heart failure?. South Med J. 102(8), 870-1.
R
Cholongitas, E., Antoniadis N., Goulis I., Fouzas I., Vasiliadis T., Akriviadis E., et al. (2016).  Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.. Liver Transpl. 22(1), 132-3.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome. World Journal of Gastroenterology. 24(12), 1285 - 1298.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome.. World J Gastroenterol. 24(12), 1285-1298.
Cholongitas, E., Calvaruso V., Senzolo M., Patch D., Shaw S., O'Beirne J., et al. (2009).  RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit.. J Gastroenterol Hepatol. 24(10), 1639-47.
Theocharidou, E., Pieri G., Mohammad A. Omar, Cheung M., Cholongitas E., Agarwal B., et al. (2014).  The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score.. Am J Gastroenterol. 109(4), 554-62.
S
Pipili, C., Cholongitas E., GIANNIKAKI E., & Ioannidou D. (2009).  Skin infection masquerading as lupus erythematosous profundus.. Eur J Dermatol. 19(5), 521-2.
Cholongitas, E., Georgousaki C., Spyrou S., Rellos K., & Dasenaki M. (2009).  Staphylococcal pneumonia with multiple muscle abscesses in an immunocompetent patient.. Int J Infect Dis. 13(6), e521.
Cholongitas, E., Georgousaki C., Spyrou S., Katsogridakis K., & Dasenaki M. (2009).  Stevens-Johnson syndrome related to ciprofloxacin, possibly enhanced by overadministration of levothyroxine.. Dermatol Online J. 15(11), 16.
T
Triantos, C. K., Samonakis D., Thalheimer U., Cholongitas E., Senzolo M., Marelli L., et al. (2010).  Terlipressin therapy for renal failure in cirrhosis.. Eur J Gastroenterol Hepatol. 22(4), 481-6.
Papatheodoridis, G. V., Chrysanthos N., Cholongitas E., Pavlou E., Apergis G., Tiniakos D. G., et al. (2009).  Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.. J Hepatol. 51(5), 931-8.
Cholongitas, E., Germani G., Tsochatzis E., & Burroughs A. K. (2009).  Towards a better liver allocation system.. J Hepatol. 51(4), 827-8.
Marelli, L., Shusang V., Buscombe J. R., Cholongitas E., Stigliano R., Davies N., et al. (2009).  Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.. J Nucl Med. 50(6), 871-7.
Cholongitas, E., & Ilonidis G. (2010).  Transmission of varicella-zoster virus originating from a patient with localized herpes zoster: Implications for infection control?. Am J Infect Control. 38(8), 669-70.
Cholongitas, E., Nakouti T., & Akriviadis E. (2014).  Tuberculous peritonitis after treatment for chronic hepatitis C.. Ann Gastroenterol. 27(4), 435-436.
Pipili, C., Cholongitas E., & Tzanatos H. (2009).  Two cases of silent superior vena cava syndrome associated with vascular access and end-stage renal disease.. Int J Artif Organs. 32(12), 883-8.
Doumtsis, P., Oikonomou T., Goulis I., Zachou K., Dalekos G., & Cholongitas E. (2018).  Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia.. Ann Gastroenterol. 31(1), 123-126.
U
Cholongitas, E., Goulis I., Ioannidou M., Soulaidopoulos S., Chalevas P., & Akriviadis E. (2017).  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.. Hepatol Int. 11(3), 306-314.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές